Cargando…
Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study
The background to this study was that factors associated with carcinoid heart disease (CHD) and its impacts on overall survival (OS) are scantly investigated in patients (pts) with neuroendocrine tumors (NETs). In terms of materials and methods, a retrospective multicenter cohort study was conducted...
Autores principales: | Uema, Deise, Alves, Carolina, Mesquita, Marcella, Nuñez, Jose Eduardo, Siepmann, Timo, Angel, Martin, Rego, Juliana F. M., Weschenfelder, Rui, Rocha Filho, Duilio R., Costa, Frederico P., Barros, Milton, O’Connor, Juan M., Illigens, Ben M., Riechelmann, Rachel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463128/ https://www.ncbi.nlm.nih.gov/pubmed/30909590 http://dx.doi.org/10.3390/jcm8030405 |
Ejemplares similares
-
Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study
por: Tanaka, Hugo, et al.
Publicado: (2020) -
High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease
por: Alves, Carolina, et al.
Publicado: (2018) -
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022) -
Carcinoid syndrome: update on the pathophysiology and treatment
por: de Celis Ferrari, Anezka C. Rubin, et al.
Publicado: (2018) -
Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data
por: Hassan, Waleed M., et al.
Publicado: (2020)